Literature DB >> 14758095

Relevance of breast cancer cell lines as models for breast tumours: an update.

Marc Lacroix1, Guy Leclercq.   

Abstract

The number of available breast cancer cell (BCC) lines is small, and only a very few of them have been extensively studied. Whether they are representative of the tumours from which they originated remains a matter of debate. Whether their diversity mirrors the well-known inter-tumoural heterogeneity is another essential question. While numerous similarities have long been found between cell lines and tumours, recent technical advances, including the use of micro-arrays and comparative genetic analysis, have brought new data to the discussion. This paper presents most of the BCC lines that have been described in some detail to date. It evaluates the accuracy of the few of them widely used (MCF-7, T-47D, BT-474, SK-BR-3, MDA-MB-231, Hs578T) as tumour models. It is concluded that BCC lines are likely to reflect, to a large extent, the features of cancer cells in vivo. The importance of oestrogen receptor-alpha (gene ESR1 ) and Her-2/ neu ( ERBB2 ) as classifiers for cell lines and tumours is underlined. The recourse to a larger set of cell lines is suggested since the exact origin of some of the widely used lines remains ambiguous. Investigations on additional specific lines are expected to improve our knowledge of BCC and of the dialogue that these maintain with their surrounding normal cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14758095     DOI: 10.1023/B:BREA.0000014042.54925.cc

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  285 in total

1.  Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues.

Authors:  Kun Yuan; Natalya Frolova; Yi Xie; Dezhi Wang; Leah Cook; Yeon-Jin Kwon; Adam D Steg; Rosa Serra; Andra R Frost
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

2.  Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies.

Authors:  Semir Vranic; Zoran Gatalica; Zhao-Yi Wang
Journal:  Oncol Lett       Date:  2011-11       Impact factor: 2.967

3.  Effect of radiation treatment on newly established human breast cancer cell lines MACL-1 and MGSO-3.

Authors:  Caryne Margotto Bertollo; Cristiane Rodrigues Correa; Dawidson Assis Gomes; Elaine Maria Souza-Fagundes; Alfredo Miranda Goes
Journal:  Tumour Biol       Date:  2010-04-27

4.  miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress.

Authors:  Jiening Xiao; Huixian Lin; Xiaobin Luo; Xiaoyan Luo; Zhiguo Wang
Journal:  EMBO J       Date:  2011-01-07       Impact factor: 11.598

5.  Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.

Authors:  Brian J Park; Zakary L Whichard; Seth J Corey
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

6.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

7.  Lipocalin 2 promotes breast cancer progression.

Authors:  Jiang Yang; Diane R Bielenberg; Scott J Rodig; Robert Doiron; Matthew C Clifton; Andrew L Kung; Roland K Strong; David Zurakowski; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.

Authors:  Donato Tedesco; Jianhuan Zhang; Lan Trinh; Guita Lalehzadeh; Rene Meisner; Ken D Yamaguchi; Daniel L Ruderman; Harald Dinter; Deborah A Zajchowski
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

9.  Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.

Authors:  Mary S Sakla; Nader S Shenouda; Pete J Ansell; Ruth S Macdonald; Dennis B Lubahn
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

10.  Tuning the cytotoxic properties of new ruthenium(III) and ruthenium(II) complexes with a modified bis(arylimino)pyridine Schiff base ligand using bidentate pyridine-based ligands.

Authors:  Ariadna Garza-Ortiz; Palanisamy Uma Maheswari; Martin Lutz; Maxime A Siegler; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2014-01-16       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.